2-deoxy-2-fluorogalactose has been researched along with Hepatocellular Carcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bak-Fredslund, KP; Keiding, S; Munk, OL; Sørensen, M | 1 |
| Bender, D; Frisch, K; Keiding, S; Sørensen, M | 1 |
| Fujiwara, T; Fukuda, H; Goto, R; Ido, T; Itoh, M; Iwata, R; Murata, K; Tada, M; Takahashi, J; Yoshioka, S | 1 |
| Fukuda, H | 1 |
4 other study(ies) available for 2-deoxy-2-fluorogalactose and Hepatocellular Carcinoma
| Article | Year |
|---|---|
2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
Topics: Aged; Carcinoma, Hepatocellular; Fucose; Galactose; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2016 |
The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Hepatocellular; Feasibility Studies; Female; Fucose; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
[A case of hepatocellular carcinoma with lumbar bone metastasis with high uptake of 18F-fluorodeoxygalactose in PET].
Topics: Carcinoma, Hepatocellular; Female; Fluorine Radioisotopes; Fucose; Humans; Liver Neoplasms; Lumbar Vertebrae; Middle Aged; Spinal Neoplasms; Tomography, Emission-Computed | 1994 |
[Diagnosis of liver tumors with 18F-FDG and 18F-FDGal using PET].
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Fucose; Humans; Liver Neoplasms; Tomography, Emission-Computed | 1991 |